237 related articles for article (PubMed ID: 23443317)
1. Molecular hierarchy of heparin-binding EGF-like growth factor-regulated angiogenesis in triple-negative breast cancer.
Yotsumoto F; Tokunaga E; Oki E; Maehara Y; Yamada H; Nakajima K; Nam SO; Miyata K; Koyanagi M; Doi K; Shirasawa S; Kuroki M; Miyamoto S
Mol Cancer Res; 2013 May; 11(5):506-17. PubMed ID: 23443317
[TBL] [Abstract][Full Text] [Related]
2. An isoflavone derivative potently inhibits the angiogenesis and progression of triple-negative breast cancer by targeting the MTA2/SerRS/VEGFA pathway.
Zhang X; Zou G; Li X; Wang L; Xie T; Zhao J; Wang L; Jiao S; Xiang R; Ye H; Shi Y
Cancer Biol Med; 2020 Aug; 17(3):693-706. PubMed ID: 32944400
[No Abstract] [Full Text] [Related]
3. Activation of GPER suppresses migration and angiogenesis of triple negative breast cancer via inhibition of NF-κB/IL-6 signals.
Liang S; Chen Z; Jiang G; Zhou Y; Liu Q; Su Q; Wei W; Du J; Wang H
Cancer Lett; 2017 Feb; 386():12-23. PubMed ID: 27836733
[TBL] [Abstract][Full Text] [Related]
4. HB-EGF and PDGF mediate reciprocal interactions of carcinoma cells with cancer-associated fibroblasts to support progression of uterine cervical cancers.
Murata T; Mizushima H; Chinen I; Moribe H; Yagi S; Hoffman RM; Kimura T; Yoshino K; Ueda Y; Enomoto T; Mekada E
Cancer Res; 2011 Nov; 71(21):6633-42. PubMed ID: 22009535
[TBL] [Abstract][Full Text] [Related]
5. Membrane type 1-matrix metalloproteinase cleaves off the NH2-terminal portion of heparin-binding epidermal growth factor and converts it into a heparin-independent growth factor.
Koshikawa N; Mizushima H; Minegishi T; Iwamoto R; Mekada E; Seiki M
Cancer Res; 2010 Jul; 70(14):6093-103. PubMed ID: 20587521
[TBL] [Abstract][Full Text] [Related]
6. Herb-sourced emodin inhibits angiogenesis of breast cancer by targeting VEGFA transcription.
Zou G; Zhang X; Wang L; Li X; Xie T; Zhao J; Yan J; Wang L; Ye H; Jiao S; Xiang R; Shi Y
Theranostics; 2020; 10(15):6839-6853. PubMed ID: 32550907
[TBL] [Abstract][Full Text] [Related]
7. HB-EGF stimulates eNOS expression and nitric oxide production and promotes eNOS dependent angiogenesis.
Mehta VB; Zhou Y; Radulescu A; Besner GE
Growth Factors; 2008 Dec; 26(6):301-15. PubMed ID: 18925469
[TBL] [Abstract][Full Text] [Related]
8. IGFBP7 reduces breast tumor growth by induction of senescence and apoptosis pathways.
Benatar T; Yang W; Amemiya Y; Evdokimova V; Kahn H; Holloway C; Seth A
Breast Cancer Res Treat; 2012 Jun; 133(2):563-73. PubMed ID: 21997538
[TBL] [Abstract][Full Text] [Related]
9. HMGA1 promotes breast cancer angiogenesis supporting the stability, nuclear localization and transcriptional activity of FOXM1.
Zanin R; Pegoraro S; Ros G; Ciani Y; Piazza S; Bossi F; Bulla R; Zennaro C; Tonon F; Lazarevic D; Stupka E; Sgarra R; Manfioletti G
J Exp Clin Cancer Res; 2019 Jul; 38(1):313. PubMed ID: 31311575
[TBL] [Abstract][Full Text] [Related]
10. Regulatory mechanisms of the HB-EGF autocrine loop in inflammation, homeostasis, development and cancer.
Miyata K; Yotsumoto F; Nam SO; Kuroki M; Miyamoto S
Anticancer Res; 2012 Jun; 32(6):2347-52. PubMed ID: 22641673
[TBL] [Abstract][Full Text] [Related]
11. The targetable nanoparticle BAF312@cRGD-CaP-NP represses tumor growth and angiogenesis by downregulating the S1PR1/P-STAT3/VEGFA axis in triple-negative breast cancer.
Gong K; Jiao J; Xu C; Dong Y; Li D; He D; Zhao D; Yu J; Sun Y; Zhang W; Bai M; Duan Y
J Nanobiotechnology; 2021 May; 19(1):165. PubMed ID: 34059068
[TBL] [Abstract][Full Text] [Related]
12. Changes in retinal gene expression in proliferative vitreoretinopathy: glial cell expression of HB-EGF.
Hollborn M; Tenckhoff S; Jahn K; Iandiev I; Biedermann B; Schnurrbusch UE; Limb GA; Reichenbach A; Wolf S; Wiedemann P; Kohen L; Bringmann A
Mol Vis; 2005 Jun; 11():397-413. PubMed ID: 15988409
[TBL] [Abstract][Full Text] [Related]
13. Expression of HB-EGF by retinal pigment epithelial cells in vitreoretinal proliferative disease.
Hollborn M; Iandiev I; Seifert M; Schnurrbusch UE; Wolf S; Wiedemann P; Bringmann A; Kohen L
Curr Eye Res; 2006 Oct; 31(10):863-74. PubMed ID: 17050278
[TBL] [Abstract][Full Text] [Related]
14. Development of anti-HB-EGF immunoliposomes for the treatment of breast cancer.
Nishikawa K; Asai T; Shigematsu H; Shimizu K; Kato H; Asano Y; Takashima S; Mekada E; Oku N; Minamino T
J Control Release; 2012 Jun; 160(2):274-80. PubMed ID: 22020380
[TBL] [Abstract][Full Text] [Related]
15. Discovery of structure-based small molecular inhibitor of αB-crystallin against basal-like/triple-negative breast cancer development in vitro and in vivo.
Chen Z; Ruan Q; Han S; Xi L; Jiang W; Jiang H; Ostrov DA; Cai J
Breast Cancer Res Treat; 2014 May; 145(1):45-59. PubMed ID: 24710637
[TBL] [Abstract][Full Text] [Related]
16. Hedgehog signalling pathway orchestrates angiogenesis in triple-negative breast cancers.
Di Mauro C; Rosa R; D'Amato V; Ciciola P; Servetto A; Marciano R; Orsini RC; Formisano L; De Falco S; Cicatiello V; Di Bonito M; Cantile M; Collina F; Chambery A; Veneziani BM; De Placido S; Bianco R
Br J Cancer; 2017 May; 116(11):1425-1435. PubMed ID: 28441382
[TBL] [Abstract][Full Text] [Related]
17. Tropomodulin 1 expression driven by NF-κB enhances breast cancer growth.
Ito-Kureha T; Koshikawa N; Yamamoto M; Semba K; Yamaguchi N; Yamamoto T; Seiki M; Inoue J
Cancer Res; 2015 Jan; 75(1):62-72. PubMed ID: 25398440
[TBL] [Abstract][Full Text] [Related]
18. Ascofuranone suppresses EGF-induced HIF-1α protein synthesis by inhibition of the Akt/mTOR/p70S6K pathway in MDA-MB-231 breast cancer cells.
Jeong YJ; Cho HJ; Magae J; Lee IK; Park KG; Chang YC
Toxicol Appl Pharmacol; 2013 Dec; 273(3):542-50. PubMed ID: 24096035
[TBL] [Abstract][Full Text] [Related]
19. HB-EGF orchestrates the complex signals involved in triple-negative and trastuzumab-resistant breast cancer.
Yotsumoto F; Oki E; Tokunaga E; Maehara Y; Kuroki M; Miyamoto S
Int J Cancer; 2010 Dec; 127(11):2707-17. PubMed ID: 20499311
[TBL] [Abstract][Full Text] [Related]
20. Centromere protein U (CENPU) enhances angiogenesis in triple-negative breast cancer by inhibiting ubiquitin-proteasomal degradation of COX-2.
Pan T; Zhou D; Shi Z; Qiu Y; Zhou G; Liu J; Yang Q; Cao L; Zhang J
Cancer Lett; 2020 Jul; 482():102-111. PubMed ID: 31705927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
